Role of renal dopaminergic activity on renal sodium-water metabolism in congestive heart failure

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 10-11, 1996, Pages 874-877

  Hayashi, Manabu ^a   Shimamoto, Kazuaki ^a   Tsuchihashi, Kazufumi ^a   Ishiguro, Toshiya ^a   Torii, Taka Aki ^a   Sawai, Niroh ^a   Mukai, Hiroya ^a   Iimura, Osamu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congestive heart failure; Plasma L dopa concentration; Renal dopaminergic activity; REnal sodium handling; Urinary free dopamine

Indexed keywords

DOPAMINE; LEVODOPA;

ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC SYSTEM; ELECTROCARDIOGRAM; HUMAN; KIDNEY FUNCTION; NORMAL HUMAN; SODIUM EXCRETION; SODIUM METABOLISM; WATER METABOLISM;

EID: 0029829678     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01136.x     Document Type: Article

References (24)

1. Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int. 1987; 31: 1402-15.
2. Ritz E, Flister D. The kidney in congestive heart failure. Eur. Heart J. 1991; 12 (Suppl. C): 14-20.
3. Bertorello A, Hokfelt T, Goldstein M. Proximal tubule Na-K-ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am. J. Physiol. 1988; 254: F795-801.
4. Hayashi M, Yamaji Y, Kitajima T. Aromatic L-amino-acid decarboxylase activity along the rat nephron. Am. J. Physiol. 1990; 258: F28-33.
5. Jose PA, Raymond MD, Bates A. The renal dopamine receptors. J. Am. Soc. Nephrol. 1992; 2: 1265-78.
6. Kuchel O, Cuche JL, Buu NT et al. Catecholamines excretion in 'idiopathic' edema: Decreased dopamine excretion, a pathogenic factor? J. Clin. Endocrinol. Metab. 1977; 44: 639-46.
7. Iimura O, Yamaji I, Kikuchi K. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension. Jpn. Circ. J. 1987; 51: 1232-40.
8. Nakaya Y, Katayama T, Nomura M et al. Pathophysiologic significance of free and conjugated dopamines in congestive heart failure. Am. Heart J. 1994; 127: 613-17.
9. Francis GS, Goldsmith SR, Pierpont G, Cohn JN. Free and conjugated plasma catecholamines in patients with congestive heart failure. J. Lab. Clin. Med. 1984; 103: 393-8.
10. Kissinger PT, Riggin RM, Alcorn RI, Rau LD. Estimation of catecholamines in urine by high performance liquid chromatography with electrochemical detection. Biochem. Med. 1975; 13: 299-306.
11. Moyer TP, Jiang NS, Tyce GM, Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: Methodology and clinical interpretation of results. Clin. Chem. 1979; 25: 256-63.
12. Jaffe M. Ueber den Niederschlag, welchen Pikrin saure in normblem Harn erzeugt und Ueber eine neue Reaction des Kreatinins. Z. Physiol. Chem. 1886; 10: 391-400.
13. Viquerat CE, Daly P, Swedberg K et al. Endogenous catecholamine levels in S chronic heart failure. Am. J. Med. 1985; 78: 455-60.
14. Carey RM, Siragy HM, Felder RA. Physiological modulation of renal function by the renal dopaminergic system. J. Auton. Pharmacol. 1990; 10 (Suppl. 1): S47-51.
15. Mcgrath BP, Lim AE, Bode KC et al. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: Evidence against significant dopaminergic innervation. Clin. Exp. Pharmacol. Physiol. 1983; 10: 543-53.
16. Brown MJ, Allison DJ. Renal conversion of plasma DOPA to urine dopamine. Br. J. Clin. Pharmacol. 1988; 12: 251-3.
17. Unger T, Buu NT, Kuchel O. Conjugated dopamine: Peripheral origin, distribution, and response to acute stress in the dog. Can. J. Physiol. Pharmacol. 1980; 58: 22-7.
18. Bell C, Lang WJ, Laska F. Dopamine-containing vasomotor nerves in the dog kidney. J. Neurochem. 1978; 31: 77-84.
19. Dinerstein RJ, Vannice J, Henderson RC et al. Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney. Science 1979; 205: 497-9.
20. Van Loon GR. Plasma dopamine: Regulation and significance. Fed. Proc. 1983; 42: 3012-18.
21. Brown MJ, Dollery CT. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br. J. Clin. Pharmacol. 1981; 12: 79-83.
22. Lee MR. Dopamine and the kidney: Ten years on. Clin. Sci. 1993; 84: 357-75.
23. Williams M, Young JB, Rose RM et al. Effect of protein ingestion on urinary dopamine excretion: Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenyl-alanine in man. J. Clin. Invest. 1986; 78: 1687-93.
24. Leigh FSM, Young JB. Evidence that circulating 3,4-dihydroxyphenylalanine (DOPA) is not of neuronal origin. Clin. Res. 1990; 38: 342A (abstract).